The Role of TVSG and HS in Determining Endometrial Pathologies

Ultrasound and Hysteroscopy's Place on the Diagnosis of Abnormal Uterin Bleeding

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03441087

Enrollment

216

Registered

2018-02-22

Start date

2011-01-01

Completion date

2011-12-31

Last updated

2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal Uterine Bleeding

Keywords

transvaginal ultrasonography, hysteroscopy, abnormal uterine bleeding

Brief summary

Although hysteroscopy (HS) and transvaginal ultrasonography (TVSG) are methods in the diagnosis of AUB, there is some suspicion about their efficacy. The aim of this study was to determine the efficacy and safety of HS and TVSG on diagnosing abnormal uterine bleeding(AUB) .216 women admitted to the investigators clinic (Sisli Ethal Training and Research Hospital, Obstetrics and Gynecology Department Obstetrics Service ) between 21-51 years of age. These patients were divided into two groups; menopause (71women) and pre-menopause (145 women). HS and endometrial sampling were performed both groups after TVSG.The success of these methods was assessed by kappa analysis

Interventions

DEVICETransvaginal ultrasound

DEVICEHysteroscopy

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

FEMALE

Age

21 Years to 51 Years

Healthy volunteers

Yes

Inclusion criteria

* patients who have no history of hysteroscopy and curettage, * patients who have no history of ovulatory dysfunction * women who have active vaginal bleeding.

Exclusion criteria

* presence of genital infections/PID * presence of pregnancy * presence of vaginal or cervical pathology causing vaginal bleeding * women who are receiving hormonal treatment (COC/HRT) * patients formerly diagnosed with endometrial pathology * patients having coagulopathy * women who are using intrauterine device.

Design outcomes

Primary

Measure	Time frame	Description
accuracy of diagnostic performance transvaginal ultrasonography and hysteroscopy	up to 12 month	The main outcome variable of the study was accuracy of diagnostic performance of transvaginal ultrasonography and hysteroscopy in premenopausal and menopausal women with abnormal uterin bleeding .

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026